Wayne D Hall

Summary

Affiliation: University of Queensland
Country: Australia

Publications

  1. ncbi Ethical issues in using a cocaine vaccine to treat and prevent cocaine abuse and dependence
    W Hall
    Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland, Australia 4072
    J Med Ethics 30:337-40. 2004
  2. ncbi The impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia
    Carolyn Day
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales Level 2, Darlinghurst, NSW 2010, Australia
    BMC Public Health 5:84. 2005
  3. ncbi Was an increase in cocaine use among injecting drug users in New South Wales, Australia, accompanied by an increase in violent crime?
    Louisa Degenhardt
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    BMC Public Health 5:40. 2005
  4. ncbi Using intervention time series analyses to assess the effects of imperfectly identifiable natural events: a general method and example
    Stuart Gilmour
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW 2052, Australia
    BMC Med Res Methodol 6:16. 2006
  5. ncbi Neuroscience research on the addictions: a prospectus for future ethical and policy analysis
    Wayne Hall
    Office of Public Policy and Ethics, Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD, 4072, Brisbane, Australia
    Addict Behav 29:1481-95. 2004
  6. ncbi The prediction of disease risk in genomic medicine
    Wayne D Hall
    Institute for Molecular Bioscience of the University of Queensland in St Lucia, Queensland, Australia
    EMBO Rep 5:S22-6. 2004
  7. ncbi Feeling 'better than well'
    Wayne Hall
    Office of Public Policy and Ethics in the Institute for Molecular Bioscience at the University of Queensland, St Lucia, Australia
    EMBO Rep 5:1105-9. 2004
  8. ncbi Cannabis use and psychotic disorders: an update
    Wayne Hall
    Office of Public Policy and Ethics, Institute for Molecular Bioscience University of Queensland Australia
    Drug Alcohol Rev 23:433-43. 2004
  9. ncbi Being realistic about benefits of supervised injecting facilities
    Wayne Hall
    Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland 4072, Australia
    Lancet 366:271-2. 2005
  10. ncbi Cannabinoids and cancer: causation, remediation, and palliation
    Wayne Hall
    Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland, Australia
    Lancet Oncol 6:35-42. 2005

Detail Information

Publications71

  1. ncbi Ethical issues in using a cocaine vaccine to treat and prevent cocaine abuse and dependence
    W Hall
    Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland, Australia 4072
    J Med Ethics 30:337-40. 2004
    ..There will need to be an informed community debate about what role, if any, a cocaine vaccine may have as a way of preventing cocaine addiction in children and adolescents...
  2. ncbi The impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia
    Carolyn Day
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales Level 2, Darlinghurst, NSW 2010, Australia
    BMC Public Health 5:84. 2005
    ....
  3. ncbi Was an increase in cocaine use among injecting drug users in New South Wales, Australia, accompanied by an increase in violent crime?
    Louisa Degenhardt
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    BMC Public Health 5:40. 2005
    ..Specifically, the paper aims to examine the impact of increased cocaine use among Sydney IDU upon police incidents of robbery with a weapon, assault and homicide...
  4. ncbi Using intervention time series analyses to assess the effects of imperfectly identifiable natural events: a general method and example
    Stuart Gilmour
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW 2052, Australia
    BMC Med Res Methodol 6:16. 2006
    ..ITSA methods are quasi-experimental in nature and the validity of modelling with these methods depends upon assumptions about the timing of the intervention and the response of the process to it...
  5. ncbi Neuroscience research on the addictions: a prospectus for future ethical and policy analysis
    Wayne Hall
    Office of Public Policy and Ethics, Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD, 4072, Brisbane, Australia
    Addict Behav 29:1481-95. 2004
    ....
  6. ncbi The prediction of disease risk in genomic medicine
    Wayne D Hall
    Institute for Molecular Bioscience of the University of Queensland in St Lucia, Queensland, Australia
    EMBO Rep 5:S22-6. 2004
  7. ncbi Feeling 'better than well'
    Wayne Hall
    Office of Public Policy and Ethics in the Institute for Molecular Bioscience at the University of Queensland, St Lucia, Australia
    EMBO Rep 5:1105-9. 2004
  8. ncbi Cannabis use and psychotic disorders: an update
    Wayne Hall
    Office of Public Policy and Ethics, Institute for Molecular Bioscience University of Queensland Australia
    Drug Alcohol Rev 23:433-43. 2004
    ..It seems more likely that cannabis use can precipitate schizophrenia in vulnerable individuals. There is also reasonable evidence for the third hypothesis that cannabis use exacerbates psychosis...
  9. ncbi Being realistic about benefits of supervised injecting facilities
    Wayne Hall
    Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland 4072, Australia
    Lancet 366:271-2. 2005
  10. ncbi Cannabinoids and cancer: causation, remediation, and palliation
    Wayne Hall
    Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland, Australia
    Lancet Oncol 6:35-42. 2005
    ..We review the available evidence on these three issues and consider their implications for policy...
  11. ncbi Will nicotine genetics and a nicotine vaccine prevent cigarette smoking and smoking-related diseases?
    Wayne D Hall
    Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland, Australia
    PLoS Med 2:e266; quiz e351. 2005
  12. ncbi Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs
    Wayne D Hall
    Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, St Lucia, QLD, 4072, Australia
    Drug Alcohol Rev 24:39-48. 2005
    ....
  13. ncbi The contribution of research to Australian policy responses to heroin dependence 1990-2001: a personal retrospection
    Wayne Hall
    Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, St Lucia, Australia
    Addiction 99:560-9. 2004
    ....
  14. ncbi Retrospections of a recovering drug researcher
    Wayne Hall
    Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, Australia
    Addiction 99:153-4. 2004
  15. ncbi The prospects for immunotherapy in smoking cessation
    Wayne Hall
    Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, UK
    Lancet 360:1089-91. 2002
  16. ncbi The genetics of tobacco use: methods, findings and policy implications
    W Hall
    Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland 4072, Australia
    Tob Control 11:119-24. 2002
    ..advances in molecular biology, including the completion of the draft sequence of the human genome, interest has now turned to identifying gene markers that predict a heightened risk of using tobacco and developing nicotine dependence..
  17. ncbi Addiction, ethics and scientific freedom
    Wayne Hall
    Office of Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, St Lucia, Australia
    Addiction 98:873-4. 2003
  18. ncbi Breaking the deadlock over an Australian trial of injectable opioid maintenance
    Wayne D Hall
    Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, St Lucia
    Med J Aust 176:72-3. 2002
  19. ncbi Medical marijuana initiatives : are they justified? How successful are they likely to be?
    Wayne Hall
    Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia
    CNS Drugs 17:689-97. 2003
    ..While awaiting these developments, patients with specified medical conditions could be given exemptions from criminal prosecution to grow cannabis for their own use, at their own risk...
  20. ncbi The policy and ethical implications of genetic research on attention deficit hyperactivity disorder
    Max Yeh
    Office of Public Policy and Ethics, Institute for Molecular Bioscience, The University of Queensland, St Lucia Queensland, 4072, Australia
    Aust N Z J Psychiatry 38:10-9. 2004
    ..Researchers and clinicians need to be mindful of these issues in interpreting and disseminating the results of genetic studies of ADHD...
  21. ncbi Would vaccination against nicotine be a cost-effective way to prevent smoking uptake in adolescents?
    Coral E Gartner
    UQ Centre for Clinical Research, The University of Queensland, Herston, Brisbane, Australia
    Addiction 107:801-9. 2012
    ..We used epidemiological modelling to assess whether nicotine vaccines would be a cost-effective way of preventing smoking uptake in adolescents...
  22. ncbi What are the major drivers of prevalent disability burden in young Australians?
    Rebecca R S Mathews
    Centre for Clinical Research, University of Queensland, Brisbane, QLD, Australia
    Med J Aust 194:232-5. 2011
    ..To examine age and sex differences in the leading causes of prevalent disability in young Australians...
  23. ncbi How can we reduce alcohol-related road crash deaths among young Australians?
    Wayne D Hall
    School of Population Health, University of Queensland, Brisbane, QLD, Australia
    Med J Aust 192:464-6. 2010
    ..If we had enforced a zero BAC until age 25, the number of deaths averted until age 25 years could have been as high as 50...
  24. ncbi Cannabis use and the mental health of young people
    Wayne D Hall
    University of Queensland, Herston, Australia
    Aust N Z J Psychiatry 40:105-13. 2006
    ..To review the evidence on the mental health and psychosocial consequences of rising rates of cannabis use among young people in developed countries...
  25. ncbi The genetics of nicotine addiction liability: ethical and social policy implications
    Wayne D Hall
    School of Population Health, The University of Queensland, Queensland, Australia
    Addiction 103:350-9. 2008
    ..To assess the promise and risks of technological applications of genetic research on liability to develop nicotine dependence...
  26. ncbi Smokeless tobacco use in Australia
    Coral E Gartner
    School of Population Health, University of Queensland, Herston, Australia
    Drug Alcohol Rev 28:284-91. 2009
    ..There has been little research published on the use of smokeless tobacco (SLT) in Australia. This study aimed to determine the prevalence of SLT use and the potential for harm reduction in current SLT users and smokers...
  27. ncbi Genetic screening for susceptibility to depression: can we and should we?
    Katherine I Morley
    Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland 4072, Australia
    Aust N Z J Psychiatry 38:73-80. 2004
    ....
  28. ncbi Depression and psychological distress in tobacco smokers and people with cannabis dependence in the National Survey of Mental Health and Wellbeing
    Rebecca R S Mathews
    Centre for Clinical Research, University of Queensland, Brisbane, QLD, Australia
    Med J Aust 195:S12-5. 2011
    ..To examine changes in the prevalence of affective disorders and psychological distress among smokers and people with cannabis dependence between 1997 and 2007...
  29. ncbi Should Australia lift its ban on low nitrosamine smokeless tobacco products?
    Coral E Gartner
    School of Population Health, University of Queensland, Brisbane, QLD, Australia
    Med J Aust 188:44-6. 2008
    ....
  30. ncbi Challenges in reducing cannabis-related harm in Australia
    Wayne D Hall
    School of Population Health, University of Queensland, Herston, Australia
    Drug Alcohol Rev 28:110-6. 2009
    ....
  31. ncbi Community perceptions on the significant extension of life: an exploratory study among urban adults in Brisbane, Australia
    Mair Underwood
    School of Population Health, The University of Queensland, Brisbane, Queensland 4072, Australia
    Soc Sci Med 68:496-503. 2009
    ....
  32. ncbi Multiple genetic tests for susceptibility to smoking do not outperform simple family history
    Coral E Gartner
    The University of Queensland, School of Population Health, Herston, QLD, Australia
    Addiction 104:118-26. 2009
    ..To evaluate the utility of using predictive genetic screening of the population for susceptibility to smoking...
  33. ncbi Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05
    Hera Lutsenko
    School of Population Health, University of Queensland, Australia
    Drug Alcohol Rev 27:160-4. 2008
    ..To compare the usage of bupropion hydrochloride and nicotine replacement in Australia between 2001 and 2005...
  34. ncbi Galvanizers, guides, champions, and shields: the many ways that policymakers use public health researchers
    Abby S Haynes
    The Sax Institute, University of Sydney, Menzies Centre for Health Policy, University of Queensland, Australia
    Milbank Q 89:564-98. 2011
    ..It also explores the extent to which policymakers' accounts of using researchers concur with the experiences of "policy-engaged" public health researchers...
  35. ncbi A research agenda for assessing the potential contribution of genomic medicine to tobacco control
    Wayne D Hall
    School of Population Health, University of Queensland, Herston Road, Herston, QLD 4006, Australia
    Tob Control 16:53-8. 2007
    ....
  36. ncbi Clinical update: codeine maintenance in opioid dependence
    Wayne D Hall
    School of Population Health, University of Queensland, Herston, Australia
    Lancet 370:550-2. 2007
  37. ncbi Should the health community promote smokeless tobacco (snus) as a harm reduction measure?
    Coral E Gartner
    School of Population Health, University of Queensland, Herston, Australia
    PLoS Med 4:e185. 2007
    ....
  38. ncbi Professional and personal attitudes of researchers in ageing towards life extension
    Mair Underwood
    Australasian Centre on Ageing, The University of Queensland, Brisbane, QLD, Australia
    Biogerontology 10:73-81. 2009
    ..Some participants were not interested in the prospect of life extension for personal reasons, because they felt the potential risks outweighed the potential benefits, or because life extension raised issues of justice and equity...
  39. ncbi The contribution of research to the development of a national cannabis policy in Australia
    Wayne D Hall
    University of Queensland, Australia
    Addiction 103:712-20. 2008
    ..To describe the formulation of a National Cannabis Strategy in Australia in 2006 and discuss the contribution that research evidence has made to its development...
  40. ncbi Minimising the misuse of oxycodone and other pharmaceutical opioids in Australia
    Wayne D Hall
    University of Queensland Centre for Clinical Research, Brisbane, QLD, Australia
    Med J Aust 195:248-9. 2011
    ..Simple strategies can reduce harms from misuse of pharmaceutical opioids...
  41. ncbi Supping with the devil? The role of law in promoting tobacco harm reduction using low nitrosamine smokeless tobacco products
    W Hall
    The University of Queensland, School of Population Health, Herston Road, Herston, QLD 4006, Australia
    Public Health 123:287-91. 2009
    ..This paper concludes with suggestions for a graduated series of policies that may allow exploration of the public health costs and benefits of encouraging smokers to switch to snus...
  42. ncbi Why do they do it? A pilot study towards understanding participant motivation and experience in a large genetic epidemiological study of endometriosis
    Susan A Treloar
    Genetic Epidemiology Laboratory, Queensland Institute of Medical Research, Brisbane, Australia
    Community Genet 10:61-71. 2007
    ..We also aimed to explore understanding of complex genetic or multifactorial conditions in general...
  43. ncbi Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study
    Coral E Gartner
    School of Population Health, The University of Queensland, Herston, Queensland, Australia
    Lancet 369:2010-4. 2007
    ..Swedish snus is a smokeless tobacco product that has been suggested as a tobacco harm reduction product. Our aim was to assess the potential population health effects of snus...
  44. ncbi Is there evidence of 'hardening' among Australian smokers between 1997 and 2007? Analyses of the Australian National Surveys of Mental Health and Well-Being
    Rebecca Mathews
    UQ Centre for Clinical Research, University of Queensland, Royal Brisbane and Women s Hospital, Herston, Brisbane, Queensland, Australia
    Aust N Z J Psychiatry 44:1132-6. 2010
    ..To use data from the 1997 and 2007 National Surveys of Mental Health and Well-Being (NSMHWB) to assess whether Australian smokers in 2007 have higher rates of mental distress and social disadvantage than smokers in 1997...
  45. ncbi How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?
    Wayne D Hall
    School of Population Health, University of Queensland, Herston, Queensland, Australia
    Aust N Z J Psychiatry 40:941-50. 2006
    ....
  46. ncbi Oral substitution treatments for opioid dependence
    Wayne D Hall
    School of Population Health, University of Queensland, Herston 4006, QLD, Australia
    Lancet 371:2150-1. 2008
  47. ncbi Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis
    Wayne D Hall
    Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia
    BMJ 326:1008. 2003
    ..If so, increased prescribing of selective serotonin reuptake inhibitors in general practice may have produced a quantifiable benefit in population mental health...
  48. ncbi Sociodemographic correlates of antidepressant utilisation in Australia
    Andrew N Page
    School of Population Health, University of Queensland, Brisbane, QLD, Australia
    Med J Aust 190:479-83. 2009
    ..To investigate sociodemographic variation in antidepressant utilisation...
  49. ncbi Patterns of antipsychotic medication use in Australia 2002-2007
    Samantha A Hollingworth
    School of Population Health, University of Queensland, Herston Road, Herston, 4006 QLD, Australia
    Aust N Z J Psychiatry 44:372-7. 2010
    ....
  50. ncbi Utilization of anti-Parkinson drugs in Australia: 1995-2009
    Samantha A Hollingworth
    The University of Queensland, School of Population Health, Herston, Australia
    Pharmacoepidemiol Drug Saf 20:450-6. 2011
    ..To examine trends in the prescribing of anti-Parkinsonian drugs (APD) in Australia from 1995 to 2009...
  51. ncbi Under what conditions is it ethical to offer incentives to encourage drug-using women to use long-acting forms of contraception?
    Jayne C Lucke
    The University of Queensland, UQ Centre for Clinical Research, Herston, QLD, Australia
    Addiction 107:1036-41. 2012
    ..To stimulate debate by examining ethical issues raised by Project Prevention, a US-based organization that offers $US300 to addicted individuals who agree to either undergo surgical sterilization or use long-acting forms of contraception...
  52. ncbi Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field
    Polly Ambermoon
    The University of Queensland, UQ Centre for Clinical Research, Australia
    Addiction 106:283-93. 2011
    ....
  53. ncbi Why we need tobacco sales data for good tobacco control
    Coral E Gartner
    School of Population Health, University of Queensland, Brisbane, QLD, Australia
    Med J Aust 192:3-4. 2010
    ..Good-quality data on tobacco sales are vital for evaluating tobacco control interventions...
  54. ncbi Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations
    Katherine I Morley
    Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, 4072 St Lucia, Queensland, Australia
    J Mol Med (Berl) 82:21-30. 2004
    ..We conclude with recommendations for the regulation and distribution of pharmacogenetic testing services and pharmacogenomic drugs...
  55. ncbi How have the SSRI antidepressants affected suicide risk?
    Wayne D Hall
    School of Population Health, University of Queensland, Herston, Queensland 4066, Australia
    Lancet 367:1959-62. 2006
  56. ncbi Smart drugs "as common as coffee": media hype about neuroenhancement
    Bradley J Partridge
    UQ Centre for Clinical Research, The University of Queensland, Herston, Queensland, Australia
    PLoS ONE 6:e28416. 2011
    ..In this study we explored how the newsprint media portrays neuroenhancement...
  57. ncbi The effect of a reduction in heroin supply on fatal and non-fatal drug overdoses in New South Wales, Australia
    Louisa J Degenhardt
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney
    Med J Aust 182:20-3. 2005
    ..To examine the impact of a sudden and dramatic decrease in heroin availability, concomitant with increases in price and decreases in purity, on fatal and non-fatal drug overdoses in New South Wales, Australia...
  58. ncbi Making new choices about antidepressants in Australia: the long view 1975-2002
    Andrea Mant
    Quality Use of Medicines, South East Health, Sydney Hospital, PO Box 1614, Sydney, NSW 2001, Australia
    Med J Aust 181:S21-4. 2004
    ..To examine trends in types of antidepressant medications prescribed in Australia between 1975 and 2002...
  59. ncbi The demise of a planned randomised controlled trial in an urban Aboriginal medical service
    Beverly M Sibthorpe
    National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT
    Med J Aust 176:273-6. 2002
    ....
  60. ncbi Assessing the wisdom of funding DrinkWise
    Wayne D Hall
    Med J Aust 185:635-6. 2006
  61. ncbi 'Occasional' and 'social' smokers: potential target groups for smoking cessation campaigns?
    Katherine I Morley
    Genetic Epidemiology Group, Queensland Institute of Medical Research, P O Royal Brisbane Hospital, Queensland
    Aust N Z J Public Health 30:550-4. 2006
    ..To describe the characteristics of self-described 'occasional' and 'social' Australian smokers...
  62. ncbi The adverse effects of cannabinoids: implications for use of medical marijuana
    Louisa Degenhardt
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    CMAJ 178:1685-6. 2008
  63. ncbi Alcohol sales data are essential for good public policies towards alcohol
    Wayne D Hall
    Med J Aust 189:188-9. 2008
  64. ncbi The demise of a planned randomised controlled trial in an urban Aboriginal medical service
    Beverly M Sibthorpe
    Med J Aust 177:222-3. 2002
  65. ncbi The effects of the market withdrawal of temazepam gel capsules on benzodiazepine injecting in Sydney, Australia
    Louisa Degenhardt
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, New South Wales, Australia
    Drug Alcohol Rev 27:145-51. 2008
    ..This study assessed the impact on benzodiazepine injection among IDU in Sydney of removing temazepam gel capsule preparations from the Australian market...
  66. ncbi Explaining the convergence of male and female smoking prevalence in Australia
    Katherine I Morley
    Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Australia
    Addiction 103:487-95. 2008
    ..To examine changes in age of tobacco experimentation and progression to daily smoking in men and women between birth cohorts that differ in exposure to public health programmes that aim to discourage smoking...
  67. ncbi Tailoring access to high cost, genetically targeted drugs
    Wayne D Hall
    Med J Aust 182:607-8. 2005
    ..Assessment of real cost effectiveness, with data linked to individual health outcomes while protecting patient privacy, is an essential challenge we need to meet...
  68. ncbi Substance use and the adolescent brain: a toxic combination?
    Dan I Lubman
    Department of Psychiarty, University of Melbourne, Victoria, Australia
    J Psychopharmacol 21:792-4. 2007
    ..Prospective studies investigating neurobiological correlates and sequelae of early adolescent drug use are urgently required to inform appropriate public health responses...
  69. ncbi UK classification of cannabis: is a change needed and why?
    Louisa Degenhardt
    Lancet 370:1541. 2007
  70. ncbi Opioid overdose deaths can occur in patients with naltrexone implants
    Amy E Gibson
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney
    Med J Aust 186:152-3. 2007
    ..These cases indicate that patients can die from opioid overdose with a naltrexone implant and blood naltrexone levels higher than reported blockade levels...
  71. ncbi Five genetic variants associated with prostate cancer
    Coral E Gartner
    N Engl J Med 358:2738-9; author reply 2741. 2008